[1]
M. Cristiani, A. Citarella, A. Belisari, G. Didoni, L. G. Mantovani, and S. Montella, “Economic evaluation of the use of saxagliptin in the treatment of type 2 diabetes in Italy”, FE, vol. 11, no. 2, pp. 103–115, Jun. 2010.